ERBB2 and breast carcinoma: In addition, the HER2-CD3-Fc bsAb strongly mediated T-cell-dependent killing of other HER2-positive tumor cells, including the ovarian cancer cell lines SKOV-3 and A1847 and the breast cancer cell lines SKBR3 and MDA-MB-231 (Figure 2C–F).